303 related articles for article (PubMed ID: 7331946)
21. Prevention of immune precipitation by purified classical pathway complement components.
Naama JK; Hamilton AO; Yeung-Laiwah AC; Whaley K
Clin Exp Immunol; 1984 Nov; 58(2):486-92. PubMed ID: 6333948
[TBL] [Abstract][Full Text] [Related]
22. Classical pathway evaluation.
Giclas PC
Curr Protoc Immunol; 2001 May; Chapter 13():Unit 13.1. PubMed ID: 18432714
[TBL] [Abstract][Full Text] [Related]
23. The properdin pathway: mechanisms of complement activation and analogies to the classical pathway.
Fearon DT; Austen KF; Ruddy S
Rheumatology; 1975; 6():2-16. PubMed ID: 1105744
[No Abstract] [Full Text] [Related]
24. Cyanate as an inactivator of complement proteins.
Schultz DR; Arnold PI
J Immunol; 1975 Dec; 115(6):1558-65. PubMed ID: 1184967
[TBL] [Abstract][Full Text] [Related]
25. Formation and function of the classical and alternative pathways of complement.
Ogle JD; Ogle CK
Clin Physiol Biochem; 1983; 1(2-5):194-213. PubMed ID: 6241120
[No Abstract] [Full Text] [Related]
26. Modulation of lymphocyte proliferative responses to mitogens and antigens by complement components C1, C4 and C2.
Laham MN; Caldwell JR; Panush RS
J Clin Lab Immunol; 1982 Oct; 9(1):39-47. PubMed ID: 6983586
[TBL] [Abstract][Full Text] [Related]
27. Inherited deficiencies of complement in man.
Ray TL; Wuepper KD
Int J Dermatol; 1977 Dec; 16(10):775-92. PubMed ID: 340392
[No Abstract] [Full Text] [Related]
28. Mode of interaction of different polyanions with the first (C1,C1) the second (C2) and the fourth (C4) component of complement. IV. Activation of C1 in serum by polyanions.
Loos M; Bitter-Suermann D
Immunology; 1976 Dec; 31(6):931-4. PubMed ID: 186401
[TBL] [Abstract][Full Text] [Related]
29. Hemolytic efficiency of cell-bound IgM: evidence that IgM-C1 complexes activate C4 molecules not hemolytic with homologous C2--C9.
Ejzemberg R; Borsos T
J Immunol; 1982 Apr; 128(4):1600-2. PubMed ID: 7061844
[TBL] [Abstract][Full Text] [Related]
30. [Complement system].
Korol' SA
Fiziol Zh; 1977; 23(3):408-16. PubMed ID: 326583
[No Abstract] [Full Text] [Related]
31. Analysis of the anticomplementary activity in sera of three African patients with parasitic and bacteriological infections.
Loos M; Dierich MP
Infect Immun; 1980 Jan; 27(1):1-5. PubMed ID: 7358423
[TBL] [Abstract][Full Text] [Related]
32. Depressed classical complement pathway activities in chronic lymphocytic leukaemia.
Füst G; Czink E; Minh D; Miszlay Z; Varga L; Hollán SR
Clin Exp Immunol; 1985 Jun; 60(3):489-95. PubMed ID: 4017286
[TBL] [Abstract][Full Text] [Related]
33. A simplified method for the preparation of EAC14 intermediate cells using human serum treated with methylprednisolone.
Kitamura F; Shimada K; Suzuki T; Nishioka K
J Immunol Methods; 1985 Dec; 85(2):363-70. PubMed ID: 3908568
[TBL] [Abstract][Full Text] [Related]
34. C56 formation in the reaction mixture of isolated complement components through the classical complement pathway.
Kitamura H; Tsuboi M; Nagaki K
Int Arch Allergy Appl Immunol; 1985; 78(1):101-7. PubMed ID: 4030125
[TBL] [Abstract][Full Text] [Related]
35. Evidence for restriction of the ability of complement to lyse homologous erythrocytes.
Houle JJ; Hoffmann EM
J Immunol; 1984 Sep; 133(3):1444-52. PubMed ID: 6430999
[TBL] [Abstract][Full Text] [Related]
36. Effect of plicatic acid on human serum complement includes interference with C1 inhibitor function.
Giclas PC
J Immunol; 1982 Jul; 129(1):168-72. PubMed ID: 6979566
[TBL] [Abstract][Full Text] [Related]
37. Evidence that C1s participates in the alternative complement pathway.
Volanakis JE; Schultz DR; Stroud RM
Int Arch Allergy Appl Immunol; 1976; 50(1):68-80. PubMed ID: 1244208
[TBL] [Abstract][Full Text] [Related]
38. Complement biosynthesis by the human hepatoma-derived cell line HepG2.
Morris KM; Aden DP; Knowles BB; Colten HR
J Clin Invest; 1982 Oct; 70(4):906-13. PubMed ID: 6288774
[TBL] [Abstract][Full Text] [Related]
39. The functional significance of complement.
Fearon DT; Ruddy S; Knostman JD; Carpenter CB; Austen KF
Adv Nephrol Necker Hosp; 1974; 4():15-35. PubMed ID: 4219991
[No Abstract] [Full Text] [Related]
40. Control of C1 activation by nascent C3b and C4b: a mechanism of feedback inhibition.
Ziccardi RJ
J Immunol; 1986 May; 136(9):3378-83. PubMed ID: 3485688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
